Environmental Justice Conference Explores a Just Recovery
The Global Environmental Justice Conference, organized by the Yale Center on Environmental Justice and co-sponsored by the Yale Sustainable Food Program and the Center on Climate Change and Health at the Yale School of Public Health, brought together scholars, practitioners, and activists from around the world and across disciplines to discuss how scholarship, social justice, and environmental management can be effectively integrated.
Fehon Chairs International Panel Presentation, Half-Day Conference
Dwain Fehon, PsyD, Associate Professor of Psychiatry, recently chaired and moderated an international panel presentation for the International Psycho-oncology Society (IPOS). He also recently chaired and moderated a half-day conference titled, “Achieving Health Equity in the Treatment of Cancer-Related Pain."
Intersections Success Story: David Castillo Azofeifa, PhD
David Castillo Azofeifa, PhD, a postdoctoral fellow at the University of California San Francisco, said that when he applied and was accepted as a fellow at the first Intersections Science Fellows Symposium, he expected it to begin and end with the three-day event for presenting his research and making connections. In reality, says Castillo Azofeifa, it was much more. “Intersections really prepares you for the job market,” he says. “It highlights you as an excellent candidate and it prepares you for what to do. And it connects you with a community of underrepresented people in the sciences.”
Intersections Success Story: Melanie McReynolds, PhD
When Melanie McReynolds, PhD, a postdoctoral researcher at Princeton, attended the first Intersections Science Fellows Symposium in January 2021, she already had three faculty job offers. But, she says, she saw the program as an opportunity to expand her network even further, to receive valuable career mentorship, and to develop her negotiating skills.
TAVR outcomes similar after 1 year in low-risk bicuspid, tricuspid aortic stenosis patients
Transcatheter aortic valve replacement (TAVR) outcomes after one year are comparable between low-risk patients with bicuspid and tricuspid aortic valves, according to new data presented at TVT 2021.Source: Cardiovascular Business
Deep Learning with SPECT Accurately Predicts Major Adverse Cardiac Events
An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac events more accurately than current standard imaging protocols, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.Source: Mirage
Results From Sequana Medical’s RED DESERT alfapump DSR® Study Selected for Presentation at the Heart Failure 2021 Online Congress
The RED DESERT alfapump DSR (Direct Sodium Removal) study has been selected for presentation at the Heart Failure 2021 Online Congress as part of the Late Breaking Science Results.Source: GlobeNewswire
EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold
One-year results of the FUTURE-II study—a randomised trial comparing a thin-strut bioresorbable scaffold to an everolimus-eluting cobalt-chromium stent—could reignite interest in the use of such devices, attendees at EuroPCR 2021 (18–20 May, virtual) heard.Source: Cardiovascular News
EuroPCR 2021: Meta-analysis supports elective coronary revascularisation
A meta-analysis of randomised trials comparing a strategy of revascularisation plus medical therapy versus medical therapy alone in patients with chronic coronary syndromes, found that an invasive strategy reduced the risk of cardiac death by up to one-fifth among these patients.Source: Cardiovascular News
Medtronic (MDT) Evolut TAVR System Shows Strong Performance at Two Years in Low Risk Trial
Medtronic announced the complete two-year outcomes from the landmark Evolut Low Risk Trial comparing the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to open-heart surgery in characteristically younger, healthier aortic stenosis patients.Source: StreetInsider Premium